Impact of obesity on ribavirin concentrations.

Åsa Alsiö (321573); Karolina Rembeck (321574); Galia Askarieh (321575); Peer Brehm Christensen (213500); Martti Färkkilä (321576); Nina Langeland (57003); Mads Rauning Buhl (321577); Court Pedersen (38784); Kristine Mørch (321579); Bart L. Haagmans (253561); Salmir Nasic (321581); Johan Westin (321583); Kristoffer Hellstrand (321584); Gunnar Norkrans (321586); Martin Lagging (321589)

doi:10.1371/journal.pone.0037521.g003

Impact of obesity on ribavirin concentrations.

By Åsa Alsiö (321573), Karolina Rembeck (321574), Galia Askarieh (321575), Peer Brehm Christensen (213500), Martti Färkkilä (321576), Nina Langeland (57003), Mads Rauning Buhl (321577), Court Pedersen (38784), Kristine Mørch (321579), Bart L. Haagmans (253561), Salmir Nasic (321581), Johan Westin (321583), Kristoffer Hellstrand (321584), Gunnar Norkrans (321586) and Martin Lagging (321589)

Abstract

Box plots displaying the 10th, 25th, 50th, 75th, and 90th percentiles of the plasma concentrations of ribavirin (µg/mL) treatment day 29 and week 12 (A and B respectively). P-values obtained using Mann-Whitney U-test.</p

Topics: Pharmacology, Infectious Diseases, Virology, obesity, ribavirin

Year: 2013

DOI identifier: 10.1371/journal.pone.0037521.g003

OAI identifier: oai:figshare.com:article/303436

Provided by: FigShare

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://figshare.com/articles/... (external link)

Impact of obesity on ribavirin concentrations.

Abstract

Suggested articles